### Comment:
They are filing for FDA approval, drug didn't fail.

### REPLY:
I can’t believe you’re getting upvoted. This drug did fail. They then narrowed the original tests patient population which showed some favorable outcomes. The FDA said ok it will let it go through the process again. 
  
 Most are thinking this is a skewed view approach. I hope it actually has meaningful patient impact but Alzheimer’s is insanely hard to find a solution for. Time will tell.

### END.